// App-Quantinova.ai

2741 : LR-CD: Efficacy of Combination Therapy with Lenalidomide for Untreated Indolent B-Cell NHL.

Researchers

Presenter

  • Stephen M Ansell

Principal Investigators

  • Katherine Gano

  • Rodger E. Tiedemann

  • Keith Stewart

  • Thomas E. Witzig

  • Amylou C. Dueck

  • Christopher Conley

  • Grzegorz S. Nowakowski

  • Kelly Curtis

  • John Camoriano

  • Jose Leis

  • James L Slack

  • Riccardo Valdez

Medical Centers

  • Research, Mayo Clinic, Scottsdale, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Non-Hodgkin's Lymphoma

  • B cell lymphomas

  • Neutropenia

  • Non‐Hodgkin Lymphoma

  • B-Cell Non-Hodgkin Lymphoma

  • Venous thrombosis

  • Lymphomas

  • Anemia

Biomarkers

  • Creatinine

  • L-plastin

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Rituximab

Outcome

  • N/A

Study Design

  • single arm

Phase

  • NA

Study Id's

  • NCT00784927

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved